7
May
2024

Prolytix

Exhibitor at CPHI North America 2024 stand 539
About Us

Prolytix performs GMP release testing for both commercial and clinical trial drug substances and drug products. We test bulk, final product, and in-process materials in our fully compliant, FDA-inspected facility. Combined with our other Chemistry, Manufacturing, and Control (CMC), Excipient and drug development services, you’re assured the highest quality from early-phase clinical development through commercial release. 

  • US
  • 2022
    On CPHI since
  • 4
    Certificates
  • 25 - 49
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Primary activities
Analytical Services
Laboratory Services
Contact info
  • 57 River Road, Essex Junction, VT, United States
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 539